Document is current
Any future updates will be listed below
-
Authors
Arns, Beatriz https://orcid.org/0000-0002-4464-9763
Horvath, Jaqueline Driemeyer C. https://orcid.org/0000-0001-8440-6590
Rech, Gabriela Soares https://orcid.org/0000-0001-5122-8820
Sesin, Guilhermo Prates https://orcid.org/0000-0002-8607-3467
Agani, Crepin Aziz Jose Oluwafoumi https://orcid.org/0000-0001-5987-1351
da Rosa, Bruna Silveira https://orcid.org/0009-0008-7547-1815
dos Santos, Tiago Marcon https://orcid.org/0000-0002-7328-6092
Brochier, Liliane Spencer Bittencourt https://orcid.org/0000-0003-0778-5018
Cavalcanti, Alexandre Biasi https://orcid.org/0000-0003-2798-6263
Tomazini, Bruno Martins https://orcid.org/0000-0001-6763-6132
Pereira, Adriano Jose https://orcid.org/0000-0002-3528-3800
Veiga, Viviane Cordeiro https://orcid.org/0000-0002-0287-3601
Nascimento, Giovana Marssola https://orcid.org/0009-0005-5071-3775
Kalil, Andre C. https://orcid.org/0000-0002-6489-6294
Zavascki, Alexandre P. https://orcid.org/0000-0001-5331-4837
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05210387 at ClinicalTrials.govDocuments that mention this clinical trial
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol
https://doi.org/10.1007/s40121-023-00897-9
-
Funding
Funding for this research was provided by:
Support Program for Institutional Development of the Unified Health System
- License Information
-
More Information
Article History
Received: 30 October 2023
Accepted: 23 November 2023
First Online: 16 December 2023
Declarations
:
: All authors confirm that they have no conflicts of interest to declare. Alexandre P. Zavascki is a research fellow of the National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Brazil.
: This study has been conducted in accordance with the Brazilian and international regulations set forth in the following documents: Declaration of Helsinki; Brazilian National Health Council Resolution CNS 466/2012 and related Brazilian Ministry of Health publications; and 1996 ICH Harmonized Tripartite Guideline for Good Clinical Practice. The study protocol and amendments have been approved by the research ethics committee (IRB) of the coordinating center (Hospital Moinhos de Vento), as well as IRBs from all other participant sites.
